LSL Pharma Group Inc. LSL.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -262.62% | -- | -- | -- |
| Total Depreciation and Amortization | -- | 76.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 162.29% | -- | -- | -- |
| Change in Net Operating Assets | -- | -49.49% | -- | -- | -- |
| Cash from Operations | -- | -2,482.07% | -- | -- | -- |
| Capital Expenditure | -- | -30.07% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 24.03% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -21.50% | -- | -- | -- |
| Cash from Investing | -- | -3.12% | -- | -- | -- |
| Total Debt Issued | -- | 173.53% | -- | -- | -- |
| Total Debt Repaid | -- | -108.60% | -- | -- | -- |
| Issuance of Common Stock | -- | -62.91% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -54.00% | -- | -- | -- |
| Cash from Financing | -- | 75.64% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 165.89% | -- | -- | -- |